PUK4 A Cost-Comparison Analysis of Treating Overactive Bladder (OAB) With Fesoterodine, Tolterodine or Solifenacin in Daily Clinical Practice in Spain
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1442
https://www.valueinhealthjournal.com/article/S1098-3015(12)03155-5/fulltext
Title :
PUK4 A Cost-Comparison Analysis of Treating Overactive Bladder (OAB) With Fesoterodine, Tolterodine or Solifenacin in Daily Clinical Practice in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03155-5&doi=10.1016/j.jval.2012.08.1442
First page :
A455
Section Title :
Urinary/Kidney Disorders
Open access? :
No
Section Order :
936